NEDD9 and breast carcinoma: To date, several signalling pathways relevant to breast cancer aetiology, including transforming growth factor (TGF)-beta, progesterone and hypoxia signalling, have been found to positively regulate Nedd9 mRNA expression [2], but less is known about the transcriptional control of p130Cas/BCAR1.